Cargando…

The Assessment of Addition of Either Intravenous Paracetamol or Diclofenac Suppositories to Patient-Controlled Morphine Analgesia for Postgastrectomy Pain Control

BACKGROUND: Major surgical procedures, such as gastrectomy, result in extensive postoperative pain, which can lead to increased morbidity, discomfort and dissatisfaction among the patients. OBJECTIVES: The aim of this study was to evaluate the effect of adding diclofenac suppositories or intravenous...

Descripción completa

Detalles Bibliográficos
Autores principales: Bameshki, Alireza, Peivandi Yazdi, Arash, Sheybani, Shima, Rezaei Boroujerdi, Hengameh, Taghavi Gilani, Mehryar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644315/
https://www.ncbi.nlm.nih.gov/pubmed/26587407
http://dx.doi.org/10.5812/aapm.29688
_version_ 1782400655287123968
author Bameshki, Alireza
Peivandi Yazdi, Arash
Sheybani, Shima
Rezaei Boroujerdi, Hengameh
Taghavi Gilani, Mehryar
author_facet Bameshki, Alireza
Peivandi Yazdi, Arash
Sheybani, Shima
Rezaei Boroujerdi, Hengameh
Taghavi Gilani, Mehryar
author_sort Bameshki, Alireza
collection PubMed
description BACKGROUND: Major surgical procedures, such as gastrectomy, result in extensive postoperative pain, which can lead to increased morbidity, discomfort and dissatisfaction among the patients. OBJECTIVES: The aim of this study was to evaluate the effect of adding diclofenac suppositories or intravenous paracetamol, on morphine consumption and on the quality of postgastrectomy pain control. PATIENTS AND METHODS: This randomized double blinded clinical trial was carried out in 90 patients with gastric cancer, who were candidates for gastrectomy, which were divided into three similar groups. The patients were transferred to an intensive care unit after the operation and received patient-controlled analgesia (PCA) with morphine, morphine PCA plus intravenous paracetamol 1 g, every 6 hours, and morphine PCA plus diclofenac suppositories, 100 mg every 8 hours. The patients were evaluated for up to 24 hours after the operation for the severity of pain, alertness, and opioid complications. RESULTS: There was no significant difference in pain scores among the three groups (P values, after extubation, at 2, 4, 6, 12, 18 and 24 hours were 0.72, 0.19, 0.21, 0.66, 0.54, 0.56, and 0.25, respectively), although morphine consumption was greater in the morphine group, compared with the other two groups (21.4 ± 7.7 mg in morphine group vs. 14.3 ± 5.8 mg in morphine-paracetamol group and 14.3 ± 3.9 in morphine-diclofenac group; P = 0.001). In morphine group, during the first 24 hours, the patients had lower levels of consciousness (P values, after extubation, at 2, 4, 6, 12, 18 and 24 hour were 0.6, 0.95, 0.28, 0.005, 0.027, 0.022 and 0.004 respectively), even though the incidence of complications was similar among the three groups. CONCLUSIONS: In this study, intravenous paracetamol or diclofenac suppositories, administered for postgastrectomy pain control, decreased morphine consumption by almost 32% and also improved alertness. Nevertheless, the amount of opioids did not affect the incidence of complications.
format Online
Article
Text
id pubmed-4644315
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-46443152015-11-19 The Assessment of Addition of Either Intravenous Paracetamol or Diclofenac Suppositories to Patient-Controlled Morphine Analgesia for Postgastrectomy Pain Control Bameshki, Alireza Peivandi Yazdi, Arash Sheybani, Shima Rezaei Boroujerdi, Hengameh Taghavi Gilani, Mehryar Anesth Pain Med Research Article BACKGROUND: Major surgical procedures, such as gastrectomy, result in extensive postoperative pain, which can lead to increased morbidity, discomfort and dissatisfaction among the patients. OBJECTIVES: The aim of this study was to evaluate the effect of adding diclofenac suppositories or intravenous paracetamol, on morphine consumption and on the quality of postgastrectomy pain control. PATIENTS AND METHODS: This randomized double blinded clinical trial was carried out in 90 patients with gastric cancer, who were candidates for gastrectomy, which were divided into three similar groups. The patients were transferred to an intensive care unit after the operation and received patient-controlled analgesia (PCA) with morphine, morphine PCA plus intravenous paracetamol 1 g, every 6 hours, and morphine PCA plus diclofenac suppositories, 100 mg every 8 hours. The patients were evaluated for up to 24 hours after the operation for the severity of pain, alertness, and opioid complications. RESULTS: There was no significant difference in pain scores among the three groups (P values, after extubation, at 2, 4, 6, 12, 18 and 24 hours were 0.72, 0.19, 0.21, 0.66, 0.54, 0.56, and 0.25, respectively), although morphine consumption was greater in the morphine group, compared with the other two groups (21.4 ± 7.7 mg in morphine group vs. 14.3 ± 5.8 mg in morphine-paracetamol group and 14.3 ± 3.9 in morphine-diclofenac group; P = 0.001). In morphine group, during the first 24 hours, the patients had lower levels of consciousness (P values, after extubation, at 2, 4, 6, 12, 18 and 24 hour were 0.6, 0.95, 0.28, 0.005, 0.027, 0.022 and 0.004 respectively), even though the incidence of complications was similar among the three groups. CONCLUSIONS: In this study, intravenous paracetamol or diclofenac suppositories, administered for postgastrectomy pain control, decreased morphine consumption by almost 32% and also improved alertness. Nevertheless, the amount of opioids did not affect the incidence of complications. Kowsar 2015-10-10 /pmc/articles/PMC4644315/ /pubmed/26587407 http://dx.doi.org/10.5812/aapm.29688 Text en Copyright © 2015, Iranian Society of Regional Anesthesia and Pain Medicine (ISRAPM). http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Research Article
Bameshki, Alireza
Peivandi Yazdi, Arash
Sheybani, Shima
Rezaei Boroujerdi, Hengameh
Taghavi Gilani, Mehryar
The Assessment of Addition of Either Intravenous Paracetamol or Diclofenac Suppositories to Patient-Controlled Morphine Analgesia for Postgastrectomy Pain Control
title The Assessment of Addition of Either Intravenous Paracetamol or Diclofenac Suppositories to Patient-Controlled Morphine Analgesia for Postgastrectomy Pain Control
title_full The Assessment of Addition of Either Intravenous Paracetamol or Diclofenac Suppositories to Patient-Controlled Morphine Analgesia for Postgastrectomy Pain Control
title_fullStr The Assessment of Addition of Either Intravenous Paracetamol or Diclofenac Suppositories to Patient-Controlled Morphine Analgesia for Postgastrectomy Pain Control
title_full_unstemmed The Assessment of Addition of Either Intravenous Paracetamol or Diclofenac Suppositories to Patient-Controlled Morphine Analgesia for Postgastrectomy Pain Control
title_short The Assessment of Addition of Either Intravenous Paracetamol or Diclofenac Suppositories to Patient-Controlled Morphine Analgesia for Postgastrectomy Pain Control
title_sort assessment of addition of either intravenous paracetamol or diclofenac suppositories to patient-controlled morphine analgesia for postgastrectomy pain control
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644315/
https://www.ncbi.nlm.nih.gov/pubmed/26587407
http://dx.doi.org/10.5812/aapm.29688
work_keys_str_mv AT bameshkialireza theassessmentofadditionofeitherintravenousparacetamolordiclofenacsuppositoriestopatientcontrolledmorphineanalgesiaforpostgastrectomypaincontrol
AT peivandiyazdiarash theassessmentofadditionofeitherintravenousparacetamolordiclofenacsuppositoriestopatientcontrolledmorphineanalgesiaforpostgastrectomypaincontrol
AT sheybanishima theassessmentofadditionofeitherintravenousparacetamolordiclofenacsuppositoriestopatientcontrolledmorphineanalgesiaforpostgastrectomypaincontrol
AT rezaeiboroujerdihengameh theassessmentofadditionofeitherintravenousparacetamolordiclofenacsuppositoriestopatientcontrolledmorphineanalgesiaforpostgastrectomypaincontrol
AT taghavigilanimehryar theassessmentofadditionofeitherintravenousparacetamolordiclofenacsuppositoriestopatientcontrolledmorphineanalgesiaforpostgastrectomypaincontrol
AT bameshkialireza assessmentofadditionofeitherintravenousparacetamolordiclofenacsuppositoriestopatientcontrolledmorphineanalgesiaforpostgastrectomypaincontrol
AT peivandiyazdiarash assessmentofadditionofeitherintravenousparacetamolordiclofenacsuppositoriestopatientcontrolledmorphineanalgesiaforpostgastrectomypaincontrol
AT sheybanishima assessmentofadditionofeitherintravenousparacetamolordiclofenacsuppositoriestopatientcontrolledmorphineanalgesiaforpostgastrectomypaincontrol
AT rezaeiboroujerdihengameh assessmentofadditionofeitherintravenousparacetamolordiclofenacsuppositoriestopatientcontrolledmorphineanalgesiaforpostgastrectomypaincontrol
AT taghavigilanimehryar assessmentofadditionofeitherintravenousparacetamolordiclofenacsuppositoriestopatientcontrolledmorphineanalgesiaforpostgastrectomypaincontrol